Category Archives: Pharmaceuticals

Featured Stories

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Pancreatitis Risk for Some Patients Taking Viberzi

Viberzi (eluxadoline), a drug to treat irritable bowel syndrome with diarrhea (IBS-D) has drawn a warning from the U.S. Food and Drug Administration (FDA) following the deaths of two patients. The patients who died did not have their gallbladders and … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Xarelto Manufacturer Leads Spending for Physicians’ Favor

Xarelto Manufacturer Leads Spending for Physicians’ Favor

The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Risperdal Litigation is Second Largest Mass Tort in Philadelphia

Risperdal Litigation is Second Largest Mass Tort in PA

Mass Tort Contains Risperdal Gynecomastia Lawsuits Lawsuits alleging the antipsychotic drug Risperdal caused gynecomastia continue to mount against Johnson & Johnson’s Janssen unit. In fact, Risperdal litigation accounts for most of the mass tort growth in Philadelphia’s Complex Litigation Center. … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Lawsuits Allege Abilify Caused Impulse-Control Problems

Lawsuits Allege Abilify Caused Impulse-Control Problems

Abilify Lawsuits Allege Gambling Addiction, Compulsive Behaviors Bristol-Myers Squibb and Otsuka Pharmaceuticals are facing lawsuits alleging that the antipsychotic medication Abilify caused impulse-control problems, including pathological gambling. Litigation continues to mount as cases are consolidated into a federal multidistrict litigation … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Serious Brain Side Effects of Dilantin

Epilepsy patients who take the drug Dilantin to control seizures could experience a variety of side effects, including atrophy of the cerebellum, an area of the brain important to the control of movement and coordination. Posture, balance, coordination and speech … Continue reading

Posted in Dilantin, Health Concerns, Pharmaceuticals |

Lawsuit Alleges Xarelto Led to Ischemic Stroke

Xarelto Lawsuits Continue to Mount Over Bleeding Injuries Bayer Healthcare AG, Johnson & Johnson, and Janssen Pharmaceuticals are facing a wrongful death lawsuit over allegations that their anticoagulant (blood thinner), Xarelto (rivaroxaban) led to a West Virginia man’s ischemic stroke … Continue reading

Posted in Pharmaceuticals |

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega is a popular antipsychotic medication increasingly associated with serious side effects such as gynecomastia, or male breast growth. Invega, known also by its generic name, paliperidone, is manufactured and distributed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Propecia Litigation Moving Toward First Trial

The litigation involving serious and sometimes catastrophic side effects of the hair loss drug Propecia is moving forward, with the selection of bellwether cases. In such large litigations, representative cases—bellwether cases—are chosen to be the first to go to trial. … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Propecia, Proscar |

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

Estrogen Product Premarin Tablets Recalled due to Labeling Issues

Estrogen Product Premarin Recalled due to Labeling Issues

Pfizer, the maker of Premarin, announced a voluntary recall of one lot of 1.25mg tablets due to an incorrect expiration date on the bottle label. What is Premarin? Premarin is an estrogen product commonly used to treat moderate to severe … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.